175 related articles for article (PubMed ID: 15596850)
1. Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer.
Thorne SH; Brooks G; Lee YL; Au T; Eng LF; Reid T
J Virol; 2005 Jan; 79(1):581-91. PubMed ID: 15596850
[TBL] [Abstract][Full Text] [Related]
2. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
Vollmer CM; Ribas A; Butterfield LH; Dissette VB; Andrews KJ; Eilber FC; Montejo LD; Chen AY; Hu B; Glaspy JA; McBride WH; Economou JS
Cancer Res; 1999 Sep; 59(17):4369-74. PubMed ID: 10485485
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.
Reid T; Galanis E; Abbruzzese J; Sze D; Wein LM; Andrews J; Randlev B; Heise C; Uprichard M; Hatfield M; Rome L; Rubin J; Kirn D
Cancer Res; 2002 Nov; 62(21):6070-9. PubMed ID: 12414631
[TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor effect of E1B55kDa-deleted adenovirus on human hepatocellular carcinoma cell lines].
Zhao J; Lü Y; Guo Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):366-8. PubMed ID: 11810762
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.
Reid T; Galanis E; Abbruzzese J; Sze D; Andrews J; Romel L; Hatfield M; Rubin J; Kirn D
Gene Ther; 2001 Nov; 8(21):1618-26. PubMed ID: 11895000
[TBL] [Abstract][Full Text] [Related]
6. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
7. p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
Harada JN; Berk AJ
J Virol; 1999 Jul; 73(7):5333-44. PubMed ID: 10364280
[TBL] [Abstract][Full Text] [Related]
8. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
9. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
Nemunaitis J; Ganly I; Khuri F; Arseneau J; Kuhn J; McCarty T; Landers S; Maples P; Romel L; Randlev B; Reid T; Kaye S; Kirn D
Cancer Res; 2000 Nov; 60(22):6359-66. PubMed ID: 11103798
[TBL] [Abstract][Full Text] [Related]
10. Effect of hypoxia on Ad5 infection, transgene expression and replication.
Shen BH; Hermiston TW
Gene Ther; 2005 Jun; 12(11):902-10. PubMed ID: 15690062
[TBL] [Abstract][Full Text] [Related]
11. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.
Shen Y; Kitzes G; Nye JA; Fattaey A; Hermiston T
J Virol; 2001 May; 75(9):4297-307. PubMed ID: 11287579
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.
Zhao J; Wang H; Wei L; Habib NA; Lu X; Wu M; Guo Y
Cancer Gene Ther; 2001 May; 8(5):333-41. PubMed ID: 11477453
[TBL] [Abstract][Full Text] [Related]
13. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection.
Goodrum FD; Ornelles DA
J Virol; 1998 Dec; 72(12):9479-90. PubMed ID: 9811681
[TBL] [Abstract][Full Text] [Related]
14. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
[TBL] [Abstract][Full Text] [Related]
15. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.
Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang G
Cancer Res; 2003 Nov; 63(22):7936-41. PubMed ID: 14633724
[TBL] [Abstract][Full Text] [Related]
16. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
Rao XM; Tseng MT; Zheng X; Dong Y; Jamshidi-Parsian A; Thompson TC; Brenner MK; McMasters KM; Zhou HS
Cancer Gene Ther; 2004 Sep; 11(9):585-93. PubMed ID: 15338010
[TBL] [Abstract][Full Text] [Related]
17. Deletion analysis of Ad5 E1a transcriptional control region: impact on tumor-selective expression of E1a and E1b.
Hedjran F; Shantanu K; Tony R
Cancer Gene Ther; 2011 Oct; 18(10):717-23. PubMed ID: 21818136
[TBL] [Abstract][Full Text] [Related]
18. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
19. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
Savelyeva I; Dobbelstein M
Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
[TBL] [Abstract][Full Text] [Related]
20. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]